Kidney Cancer Diagnostics and Therapeutics Sees New Advancement in the Market
The Global Kidney Cancer Diagnostics and Therapeutics Market was worth $3.11 billion in 2016 and estimated to be growing at a CAGR of 5.64%, to reach $4.09 billion by 2021. The frequency of kidney cancer, internationally, has accelerated in the previous years. Changes in lifestyle, immoderate smoking, elevated intake of alcohol and an upward push in obesity due to sedentary existence routines cause the growing prevalence of the disease.
View full press release